[Protein tyrosine kinase inhibitor, herbimycin A].
Uehara
Y
Y
Department of Bioactive Molecules, National Institute of Health, Tokyo, Japan.
Fukazawa
H
H
D000818:Animals; D016227:Benzoquinones; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D016391:Genes, src; D006801:Humans; D047029:Lactams, Macrocyclic; D007942:Leukemia, Experimental / Q000235:genetics / Q000473:pathology; D008213:Lymphocyte Activation / Q000187:drug effects; D014442:Monophenol Monooxygenase / Q000037:antagonists & inhibitors* / Q000235:genetics; D011809:Quinones / Q000737:chemistry / Q000494:pharmacology*; D017828:Rifabutin / Q000031:analogs & derivatives; D015398:Signal Transduction / Q000187:drug effects
D016227:Benzoquinones; D047029:Lactams, Macrocyclic; D011809:Quinones; D017828:Rifabutin; C020754:herbimycin; D014442:Monophenol Monooxygenase